Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print October 17, 2002.
Biol Reprod 2002, 10.1095/biolreprod.102.007807
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
68/2/610    most recent
biolreprod.102.007807v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Tsang, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Tsang, B. K.
Agricola
Right arrow Articles by Wang, Y.
Right arrow Articles by Tsang, B. K.
BIOLOGY OF REPRODUCTION 68, 610–619 (2003)
DOI: 10.1095/biolreprod.102.007807
© 2003 by the Society for the Study of Reproduction, Inc.


Ovary

Role and Gonadotrophic Regulation of X-Linked Inhibitor of Apoptosis Protein Expression During Rat Ovarian Follicular Development In Vitro1

Yifang Wanga,b, Peter U. Rippsteinc, and Benjamin K. Tsang2,a,b

a Reproductive Biology Unit and Division of Reproductive Medicine, b Department of Obstetrics & Gynecology and Cellular & Molecular Medicine, University of Ottawa; Ottawa Health Research Institute c Department of Laboratory Medicine, The Ottawa Hospital (Civic Campus), Ottawa, Ontario, Canada K1Y 4E9


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Although FSH up-regulates follicular cell X-linked inhibitor of apoptosis protein (XIAP) expression and suppresses apoptosis in vivo, if these events are coincidental or causally related remains to be investigated. The present study examined the role and gonadotrophic regulation of XIAP expression during follicular development in vitro. Follicles (160–210 µm) cultured for 0–6 days with FSH (100 ng/ml) showed significant growth, as evidenced by increases in follicular size, cell number, and DNA contents. Follicular XIAP content was low in the absence of FSH but was increased by the addition of gonadotropin. Apoptosis was evident in follicles cultured without FSH but was suppressed in the presence of gonadotropin. At low FSH concentration (5 ng/ml), adenoviral XIAP sense cDNA expression increased XIAP and DNA contents, reduced apoptosis, and enhanced follicular growth. Infection of the FSH-stimulated follicles with XIAP antisense elicited opposite responses. In primary granulosa cell cultures, FSH significantly increased XIAP content, inhibited apoptosis, and decreased cell number, a response potentiated by XIAP sense expression. In conclusion, the present studies demonstrated, to our knowledge for the first time, that XIAP plays an important role in the regulation of ovarian follicular development. In addition, a follicle culture system coupled to an adenoviral gene-manipulation procedure has been established and may prove to be a useful approach in assessing the role of specific genes in follicular development and atresia.

follicle, follicle-stimulating hormone, follicular development, gene regulation, ovary


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Although a cohort of follicles is recruited to develop during the estrous cycle, only a few are selected to ovulate. The remaining members of the cohort undergo atresia. An apoptosis suppressor for granulosa cells in vitro [1, 2] and in vivo [3], FSH is critical for survival of the growing follicles during development [4]. However, the cellular mechanism by which FSH elicits its antiapoptotic action is still poorly understood.

The inhibitor of apoptosis proteins (IAP; also termed baculovirus inhibitor of apoptosis repeat [BIR]-containing proteins) is a family of intracellular antiapoptotic proteins that were first identified in baculovirus. They are expressed in high abundance in proliferating cells and are suppressed in apoptotic ones. To date, six members have been identified in mammals, including X-linked IAP (XIAP, cIAP-3 [5]), human IAP-1 (HIAP-1 [5], cIAP-2 [6]), human IAP-2 (HIAP-2 [5], cIAP-1, [6]), neuronal apoptosis inhibitor protein (NAIP [7]), survivin [8], and Livin [9] (termed KIAP in kidney [10]). The IAPs are characterized by the presence of a caspase recruitment domain and N-terminal BIR motifs, which are necessary for biological activity. With the exception of NAIP and survivin, the IAPs also contain a C-terminal RING-zinc finger domain believed to be required for protein-protein interactions [11] as well as protein ubiquitination and degradation [12]. Maternal smoking-induced apoptosis of trophoblasts throughout development is associated with decreased XIAP expression [13]. Increased XIAP expression is believed to play a role in the modulation of Fas ligand-induced apoptosis in malignant glioma cells by a proliferation-inducing ligand, a member of the tumor necrosis factor (TNF) family [14]. Studies regarding the mechanisms of action of these antiapoptotic proteins suggested that IAPs modulate the activities of a group of cysteine proteases known as caspases. The XIAP has been shown to be a direct inhibitor of caspase-3 and caspase-7, which are involved in the cell surface receptor-dependent cell death pathway [15, 16], and to suppress the mitochondrial (cytochrome c-mediated) pathway by inhibiting caspase-9 activity [17]. Moreover, mammalian IAPs inhibit caspase-independent apoptosis induced by TNF{alpha} in human leukemic cells [6].

Previous studies have demonstrated in the rat ovary that XIAP and HIAP-2 were highly expressed in healthy, but not in atretic, follicles [18]. Whereas granulosa cell levels of IAP were high during gonadotropin-induced follicular development, gonadotropin withdrawal decreased granulosa cell IAP content and induced apoptosis [3]. In addition, gonadotropin-induced, NAIP-mediated suppression of apoptosis in mouse granulosa cells has been suggested to play an important role in the maintenance of oocyte survival during ovarian folliculogenesis [19]. In hen ovarian follicles during follicular development, the highest levels of the inhibitor of T-cell apoptosis (ita) gene mRNA within the granulosa cell layer were found in preovulatory (atresia-resistant) follicles, with significantly lower levels detected in prehierarchical follicles, a stage at which considerable follicular atresia is observed [20]. The above-described patterns of IAP mRNA expression during follicular development are consistent with a potential role for these genes in protecting granulosa cells from apoptosis and, thus, in maintaining follicle viability. However, the physiological roles of IAPs in follicular development and atresia remain unclear.

In the present studies, we have tested the hypothesis that XIAP expression is essential for the regulation of granulosa cell fate and follicular development by FSH. To this end, a follicle culture system coupled to an adenoviral gene-manipulation procedure has, to our knowledge for the first time, been established. Using this approach, we have demonstrated that the increase in XIAP expression induced by FSH is critical for the maintenance of normal follicular growth and development.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials

Culture media and reagents were purchased from Gibco Bethesda Research Laboratories (Burlington, ON, Canada). Agarose (low gelling temperature), DNA (calf thymus), Hoechst 33258 compound, Triton X-100, Tween 20, collagenase (type 1A), DNase 1, RNase A, bovine insulin, human transferrin, ascorbic acid, sodium selenite anhydrous, and eCG were obtained from Sigma Chemical Company (St. Louis, MO). The enhanced chemiluminescence (ECL) detection kit, [methyl-3H]thymidine (25 Ci/mmol), and [{alpha}-32P]ddATP were obtained from Amersham Life Science (Oakville, ON, Canada). Ovine FSH (NIAMDD oFSH-14) was obtained from the National Institute of Diabetes & Digestive & Kidney Diseases (Baltimore, MD). Acrylamide (electrophoresis grade), N,N'-methylene-bis-acrylamide, ammonium persulfate, glycine, SDS-PAGE prestained molecular weight standards (low range), nitrocellulose membranes, and horseradish peroxidase (HRP)-conjugated anti-rabbit and anti-mouse immunoglobulin (Ig) G were products from Bio-Rad (Richmond, CA). Rhodamine-conjugated goat anti-rabbit IgG was a product of Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Mounting medium for fluorescence was purchased from Vector Laboratories, Inc. (Vectashield, H-1000; Burlingame, CA). Cell death detection (TUNEL) kit and Terminal End Transferase (TdT) were purchased from Boehringer-Mannhein (Montreal, PQ, Canada) and Alamar Blue dye from Biosource Incorporated (distributor: Medicorp, Montreal, PQ, Canada). The Qiagen Tissue Amp Kit and QIAquick Nucleotide Removal Kit were products of Qiagen (Qiagen, Inc., Chatsworth, CA). The IM-8 Micro-injector and Joystick (MN-151) as well as Micromanipulator were purchased from Narishige International, Inc. (Long Island, NY). The stage warmer was bought from Linkam Scientific Instruments (Surry, U.K.).

Adenoviral LacZ, XIAP sense and antisense cDNAs, and rabbit polyclonal anti-human XIAP antibodies were generously provided by Dr. Eric LaCasse (Ægera Therapeutics, Inc., Ottawa, ON, Canada). Rabbit polyclonal anti-XIAP antibody was raised against a glutathione S-transferase fusion protein that was expressed in Escherichia coli using pGEX vector (Amersham Pharmacia Biotech, Arlington Heights, IL) containing full-length XIAP cDNA. The antibody was affinity-purified by passing through a glutathione S-transferase-XIAP glutathione-Sepharose column. Specificity was confirmed on Western blots (using the antibody-depleted eluate from the affinity column), and cross-reactivity with other IAPs was not noted [18]. Construction of recombinant adenovirus was carried out as described previously with some modifications [21]. Briefly, the open reading frame of XIAP was amplified by polymerase chain reaction, cloned in the pCR2.1 vector (Invitrogen, Carlsbad, CA), and sequenced. The open reading frame was cut out and ligated into the Swa-1 site of pAdex1CAwt cosmid DNA. The vector was packaged with the Promega cosmid packaging extracts (Madison, WI) and used to infect E. coli. Colonies were picked and screened for presence of the insert in the antisense orientation relative to the chicken ß-actin promoter. The CsCl-purified cosmid DNA was cotransfected with wild-type adenovirus DNA that was allowed to generate infectious adenovirus DNA only when homologous recombination with cosmid DNA occurred. The final recombinant adenovirus contained a linear, double-stranded genome of 44 820 base pairs (bp) plus the antisense XIAP insert (1500 bp). Adenoviral expression system was generated with an Ad E1 insertion vector. Virus titer was determined by the plaque assay.

Follicular Isolation and Culture

All the animal work was carried out in compliance with the Guides of the Canadian Council on Animal Care. Ovaries from 22- to 24-day-old, immature female Sprague-Dawley rats were cut into small pieces and incubated at 37°C for 30 min in {alpha}-minimal essential medium ({alpha}-MEM) containing collagenase (type 1A, 4 mg/ml) and DNase 1 (0.3 mg/ml). The incubation was terminated with the transfer of the ovarian tissues into Leibowitz L-15 medium with 0.1% (w/v) BSA, and follicles (diameter, 160–210 µm) were dissected out using 28.5-gauge needles. To minimize the experimental variation caused by damage incurred during the isolation procedures, only round follicles with an intact thecal layer on the day of isolation (Day 0) and on Day 1 of culture were selected for experimentation. Confocal microscopic examination (Bio-Rad M500; Bio-Rad Laboratories Ltd., Hertfordshire, U.K.) of the selected follicles (following fixation with paraformaldehyde [4%, v/v; 30 min; room temperature [RT]) and staining with ethidium bromide (5 mg/ml, 15 min, RT) revealed that they were at the preantral (75%) and early antral (25%; as evidenced by the presence of an antral space as large as an area occupied by approximately three granulosa cells) stages of development. Follicles were cultured individually, and follicular diameter was measured daily before medium change for 4–6 days in a 96-well plate in 100 µl of follicular culture medium (FCM; {alpha}-MEM supplemented with Hepes [10 mM], BSA [0.1%, w/v], rat serum [1%, v/v], bovine insulin [5 µg/ml], transferrin [10 µg/ml], ascorbic acid [25 µg/ml], sodium selenite anhydrous [2 ng/ml] [22], and nonessential amino acids [1%, v/v], streptomycin-penicillin [0.5%, v/v], and fungizone [0.25%, v/v]) with or without oFSH. Preliminary studies showed that inclusion of ascorbic acid and selenium in the culture medium enhanced follicular integrity, as evidenced by an increase in the proportion of intact follicles (65% ± 5.9% vs. 35% ± 4.7%; n = 3 experiments; P < 0.05) observable at the end of the 6-day culture period. At the end of the culture period, follicles were embedded in 2% (w/v) agarose, fixed in buffered formalin phosphate solution (10% [v/v], 3 h, RT), stained with Neutral Red (0.1% [w/v], 3 h, RT; to facilitate visualization of follicles during sectioning), and then processed to be embedded in paraffin. Sections (thickness, 4 µm) of the cultured follicles were also stained with Haematoxylin Phloxine Saffron (HPS) for morphologic examination.

Follicular Cell Proliferation

Follicular cell DNA assay Cultured follicles were washed twice with PBS, fixed and sonicated in trichloroacetic acid (5% [w/v], 20 min, 4°C), and finally washed twice with methanol. The DNA pellet, collected by centrifugation (16 000 x g, 10 min), was dissolved in NaOH (0.25 M) and adjusted to neutral pH with HCl (0.25 M). Aliquots of the DNA pellet and calf thymus DNA (standard) were incubated with Hoechst 33258 dye (0.1 µg/ml, 5 min in the dark, RT) as described previously [23]. Changes in fluorescence intensity were measured with a Microplate Fluorometer (SPECTRAmax GEMINIXS, Molecular Devices Corporation, Sunnyvale, CA) at excitation and emission wavelengths of 356 and 457 nm, respectively. The sensitivity and linearity of the assay were 2 and 4–1000 ng/ml, respectively.

Alamar Blue assay Alamar Blue is a nontoxic metabolic dye and has been used to monitor changes in cell numbers during tissue or primary cell culture in vitro [24, 25]. In the present studies, we have used this assay to monitor the relative increase in cell number during follicular growth under the influence of gonadotropin during a 6-day culture period. The assay was performed as described by Ahmed et al. [25]. To confirm the linear relationship between the changes in Alamar Blue reduction and those of cell number under the experimental conditions of the present studies, Alamar Blue (10% [v/v]) was first tested on primary cultures of rat granulosa cells and human ovarian surface epithelial cancer cell cultures (37°C, 6 h) and, subsequently, on rat ovarian follicle cultures (37°C, 3 h) maintained under a humidified atmosphere of 95% (v/v) air and 5% (v/v) CO2. Absorbance at wavelengths of 570 and 630 nm was measured by a fluorometer (Model MRX; Dynatech Laboratories Inc., Simi Valley, CA), and this ratio was defined as the cell number equivalence. A linear relationship between ovarian cell number and the extent of Alamar Blue reduction was established with the human epithelial ovarian cancer cell line A2780s (r2 = 0.992) and isolated rat granulosa cells (r2 = 0.980). In addition, a direct correlation was also found between Alamar Blue reduction (follicular cell number equivalence) and DNA content (r2 = 0.850) as well as follicular volume within the range of 2.2–25 nl (diameter, ~160–360 µm; r2 = 0.933) (Fig. 1). As shown in Figure 2A, an increase in follicular volume above this range, however, was not associated with a proportional increase in follicular Alamar Blue reduction, an observation consistent with the fact that the increase in follicular volume during early development is mainly a consequence of increased cell proliferation whereas that during the late stage is caused by antral enlargement. No significant change in Alamar Blue reduction was evident throughout the 6-day culture period in the absence of the gonadotropin (Fig. 2A). Maximum daily growth rate was observed on Day 3 of culture in the presence of FSH (Fig. 2B).



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 1. Linear relationship between Alamar Blue reduction, follicular volume, and DNA content. Follicles (n = 20) of different size (volume, 2.5–25 nl) were cultured individually for 24 h. Alamar Blue reagent was added during the last 3 h of culture (1:10 [v/v]). Follicular volume and DNA content were determined following Alamar Blue reduction assay



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 2. FSH increases follicular growth in vitro. Rat follicles were cultured for 6 days, with FSH (100 ng/ml) being added at the end of Day 0 or Day 2 of culture. Alamar Blue reagent was added during the last 3 h of culture on each day. Control cultures received no FSH. At the end of the daily culture period, spent medium was collected for spectrophotometer determination (optical density, 570 nm/630 nm) of cell number equivalence. Changes in DNA content and follicular size were determined as described in Materials and Methods. Follicular volume change on Day "n" of culture (A) is defined as the volume difference between Day "n" and Day 0, whereas daily follicular growth of Day "n" (B) is defined as that between Day "n" and Day "n - 1." Following confirmation that no interreplicate differences existed in each experiment (one-way ANOVA), individual observations from all replicates were pooled for analysis by two-way (repeated-measure) ANOVA. Values represent the mean ± SEM of a total of 43 follicles from three independent experiments. *P < 0.05, **P < 0.01 vs. control (no FSH)

Follicular Adenoviral Injection

To assess the role of XIAP in FSH-induced follicular development, XIAP content in the cultured follicles was manipulated by adenoviral XIAP antisense and sense (Myc-tagged) cDNA expression. After a 24-h culture in the absence of FSH in a 96-well plate, follicles were transferred onto a cell strainer (mesh size, 100 µm; Becton Dickinson Labware, Franklin Lakes, NJ) in a 35-mm dish containing FCM. Replication-deficient adenovirus containing LacZ, XIAP sense, or XIAP antisense full-length cDNAs was injected into the follicles. The volume of the virus injected was less than 10% (v/v) of the calculated follicular volume. Based on the follicular volume and estimated cell number, the amount of virus injected was multiplicity of infection (MOI) of 20 for XIAP antisense cDNA to assure adequate XIAP down-regulation. The MOI for the virus control (LacZ) was also 20. An MOI of three was chosen for XIAP sense cDNA, because it was sufficient to up-regulate XIAP expression. The FSH (5 ng/ml) was added to the cultures 24 h later, and the follicles were cultured for another 3 days. Preliminary studies indicated that follicles cultured with FSH at concentration of 100 ng/ml had higher XIAP level and were more resistant to XIAP down-regulation. In contrast, follicular XIAP level was low in the absence of FSH and less responsive to XIAP up-regulation by adenoviral sense expression. Thus, a lower concentration of oFSH (5 ng/ml) was used in subsequent cultures to achieve maximum response to XIAP up- and down-regulation by adenoviral cDNA expression.

To confirm the success of adenoviral infection, follicles injected with the adenoviral XIAP sense cDNA or LacZ were paraffin-sectioned and processed with the same procedure as described in the above section on the TUNEL assay up to the incubation step with the blocking reagents. Sections were then incubated (2 h at RT or overnight at 4°C) with HRP-conjugated anti-Myc antibody (1:50 [v/v]; Invitrogen) or rabbit anti-ß-galactosidase (1:100 [v/v]; ICN Pharmaceuticals, Inc., Biochemical Division, Aurora, OH), respectively. Sections of LacZ-infected follicles were washed in PBS, incubated with second antibody (HRP-conjugated goat anti-rabbit IgG, 1:200 [v/v] in PBS, 1 h, RT) and detected by diaminobenzidine (DAB) staining (4 min; Boehringer Mannheim Corp., Indianapolis, IN) and counterstained with Methyl Green (100%, v/v; Vector Laboratories). The Myc-tag in sections of XIAP sense-injected follicles were directly detected with DAB staining after incubation with primary antibody. In addition, adenoviral LacZ-infected follicles (MOI = 20; 3 days) were washed twice with PBS, fixed with glutaraldehyde (0.25% [v/v] in PBS, 10 min, 4°C), rinsed four times with PBS, and stained in 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal) buffer (PBS [pH 7.2–7.5] containing X-gal [1 mg/ml], K3Fe[CN]6 [5 mM], K4Fe[CN]6 [5 mM], MgCl2 [2 mM], and Triton X-100 [0.05%, v/v]; 18 h; 37°C). Stained follicles were washed twice with PBS and then incubated in a series of glycerol concentrations (10%, 20%, 40%, and 60% [v/v]; 4 h for each concentration; RT).

Successful infection of follicular cells with adenoviral LacZ and myc-tagged XIAP sense cDNA was confirmed by X-gal staining (on intact follicles) (Fig. 3, A and B) and immunohistochemistry (IHC; on follicular sections) using anti-galactosidase (87%) (Fig. 3, C and D) and anti-Myc (82%) (Fig. 3, E and F) antibodies.



View larger version (91K):
[in this window]
[in a new window]
 
FIG. 3. Validation of adenovirus gene delivery in cultured rat ovarian follicles. Adenoviral LacZ-infected follicles (MOI = 20; 3 days) were washed, fixed, stained in X-gal containing buffer, and incubated in series with increasing glycerol concentrations, as described in Materials and Methods. Shown are follicles without (A) and with (B) a full cycle of glycerol treatment (10%, 20%, 40%, and 60% [v/v]). These results indicate that adenoviral infection was successful. In addition, follicular sections were incubated with rabbit anti-ß-galactosidase (C and D) and HRP-conjugated anti-Myc antibody (E and F), as described in Materials and Methods. Magnification x40 (C and E) and x100 (D and F)

Rat Granulosa Cell Isolation and Culture

Immature female Sprague-Dawley rats (age, 24–25 days) from Charles River Canada (Montreal, PQ) were injected with eCG (15 IU i.p.), and ovaries were collected 24 h thereafter in RPMI 1640 medium supplemented with Hepes (10 mM; pH 7.4) and 10% (w/v) fetal bovine serum (FBS). Granulosa cells were harvested by follicle puncture as previously described [26], washed, and centrifuged (900 x g, 10 min). Next, 6 x 105 viable cells were plated (6-well plate, Falcon; Becton Dickinson) for 24 h in RPMI 1640 medium with 10% (w/v) FBS under a humidified atmosphere of 95% air and 5% CO2 and cultured for various durations in serum-free medium with adenoviral LacZ or antisense or sense XIAP cDNA.

Adenoviral Infection in Primary Granulosa Cell Culture System

Infection of primary granulosa cells with adenoviral XIAP sense and antisense cDNA was performed as described by Kim et al. [26]. Briefly, 1 million granulosa cells were plated in 60-mm dishes for 24 h and infected with adenoviral sense or antisense full-length XIAP or LacZ at an MOI of 5 or 20, respectively. The FSH was added to culture medium 24 h after viral infection, and granulosa cells were cultured for another 24 h. At an MOI of 10, the LacZ infection efficiency over 48 h (as determined by X-gal assay) was more than 90%, and changes in XIAP expression were confirmed by Western blot analysis.

Protein Extraction and Western Blot Analysis

Assessment of XIAP protein contents was performed according to the immunoblotting procedures described by Kim et al. [26] with minor modifications. Briefly, cultured follicles were harvested and lysed mechanically in RIPA buffer (1x PBS [pH 7.4] containing SDS [0.1%, w/v], sodium deoxycholate [0.5%, w/v], NP-40 [1%, v/v], and the protease inhibitors PMSF [1 mM], aprotinin [10 µg/ml], and sodium orthovanadate [1 mM]). The follicular lysate and harvested granulosa cells were sonicated (three times for 10 sec each on ice) in RIPA lysis buffer. Sonicates were pelleted by centrifugation (14 000 x g, 30 min, 4°C), and the supernatant was retained and stored at -20°C. Protein content of the extracts was determined with the Bio-Rad DC Protein Assay Reagent. Samples were mixed with loading buffer, resolved by 10% SDS-PAGE, and electrotransferred (30 V overnight or 80 V for 2 h) onto nitrocellulose membranes using the Bio-Rad Trans-Blot system. Nonspecific binding to the membranes was blocked with Blotto (Tris-buffered saline [TBS; pH 8.0] with 0.05% [v/v] Tween 20 [TBS-T] and 5% [w/v] dehydrated nonfat milk) at room temperature for 1 h. Membranes were then incubated (4°C, overnight) with Blotto containing rabbit anti-XIAP antibody (1:2000), washed in TBS-T (three times for 5 min each), incubated in HRP-conjugated secondary antibody (1:5000) in Blotto, and washed again in TBS-T twice and then in TBS once. Peroxidase activity was visualized with the ECL kit according to manufacturer's instructions. The XIAP content was determined by densitometrically scanning (HP ScanJet 3C; Hewlett-Packard Inc., Arlington Heights, IL) the exposed x-ray film (Kodak Canada Inc., Toronto, ON).

Cell Death Detection

Hoechst staining At the end of the granulosa cell culture period, floating cells were collected by aspiration, and cells attached to the growth surface were subjected to trypsin treatment (0.05% [w/v] trypsin and 0.53 mM EDTA, 3–5 min, 37°C). The two cell fractions (floating and attached cells) were combined, and an aliquot of this cell mixture was fixed on a microscope slide. At least 200 cells in a randomly selected area in each treatment group were counted. Apoptotic cells were identified based on their typical nuclear morphology. To avoid experimental bias, the "counter" was not aware of the treatment.

TUNEL assay TUNEL was performed as described previously [27]. Briefly, paraffin-embedded, whole-ovarian follicle sections (thickness, 4–5 µm) were mounted on positively charged slides, deparaffinized, hydrated, washed thoroughly three times for 5 min each in 1x PBS, and immersed in PBS with 0.3% (v/v) H2O2 (10 min, RT; to inhibit endogenous peroxidase activity). Following three additional 5-min washes in PBS, the sections were incubated (30 min, RT) in a blocking reagent (Large Volume DAKO LSAB Kit; DAKO Diagnostics Canada, Inc., Mississauga, ON, Canada) and immersed in 50 µl of the TUNEL mixture (47.5 µl of TUNEL label containing fluorescein isothiocyanate [FITC]-dUTP and 2.5 µl of TUNEL enzyme) in a humidified chamber (37°C, 60 min). They were mounted for fluorescence microscopy with a confocal laser-scanning system (Bio-Rad 1024). The FITC signal in TUNEL-positive cells was excited at 488 nm, with images collected within the wavelength range of 506–538 nm.

DNA fragmentation analysis Apoptotic cell death was also assessed on the basis of DNA fragmentation and confirmed through visualization of discrete DNA fragments of 185-bp multiples on agarose gel electrophoresis. Follicular DNA was extracted using Qiagen Tissue Amp Kit according to the manufacturer's instructions. The DNA was quantified spectrophotometrically by the absorbance at 260 nm. The DNA was end-labeled by incubating with TdT and [{alpha}-32P]ddATP as previously described [13]. Briefly, 500 ng of DNA sample were added to a mixture (5 µl of 5x TdT buffer, 2.5 µl of 10x CoCl2, 0.5 µl of TdT enzyme, and 0.5 µl of a 10 mCi/ml concentration of [32P]ddATP and Tris EDTA buffer) to a total volume of 25 µl and then incubated at 37°C for 60 min. Unincorporated nucleotides were removed with the Qiagen nucleotide removal kit, and the labeled samples were subsequently resolved by 1.8% (w/v) agarose. The gel was dried (3 h) and then exposed to a Bio-Rad PhosphorImager, and low-molecular-weight DNA (<4 kilobase pairs) and genomic DNA were densitometrically quantified. The gel was then exposed to x-ray film at -80°C. To correct for possible uneven gel loading, the ratio of low-molecular-weight DNA (representing apoptosis) to genomic DNA was calculated for each sample, and means of the ratios were compared. The intraobserver variability, determined by performing two separate DNA ladder analyses on the same sample, was approximately 5%.

IHC for XIAP

After incubation in TUNEL mixture, sections were immersed in rabbit polyclonal anti-human XIAP antibody (1:50) and, subsequently, in rhodamine-conjugated goat anti-rabbit IgG (1:200 in PBS, 1 h, RT). The XIAP signal (indicated by rhodamine) was generated with excitation and emission wavelengths of 568 and 630 nm, respectively. Confocal microscopic TUNEL and XIAP images were captured using NIH Image 1.61 software (available at http://rsb.info.nih.gov/nih-image).

Statistical Analysis

All experiments were carried out three to four times. Following confirmation that no interreplicate differences existed in each experiment (one-way ANOVA), individual observations from all replicates were pooled for analysis by two-way (repeated-measure) ANOVA (PRISM software version 3.0; GraphPad, San Diego, CA). When XIAP content and the apoptotic DNA fragmentation were expressed as fold of control, they were arcsine square root-transformed before one-way or two-way ANOVA. Granulosa cell number was analyzed by two-way ANOVA. Differences between experimental groups were determined by the Tukey or Bonferroni posttest. The extent of granulosa cell apoptosis between experimental groups was analyzed by the chi-square test.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
FSH Stimulates Ovarian Follicular Growth In Vitro

Follicles cultured for up to 6 days in the absence of FSH exhibited minimal growth (Day 6 vs. Day 0), as evidenced by an absence of change in follicular size (follicular volume: 3.4 ± 0.55 nl vs. 2.6 ± 0.22 nl, n = 43), cell number equivalence (2.8 ± 0.35 vs. 1.5 ± 0.15, n = 46, as determined by Alamar Blue reduction), and DNA content (2.5 ± 0.39 ng/follicle vs. 1.2 ± 0.18 ng/follicle, n = 40) (Fig. 2A). Addition of FSH (100 ng/ml) to the culture medium significantly increased these parameters (follicular volume: 33.6 ± 3.26 nl, n = 43; cell number equivalence: 11.2 ± 2.35, n = 46; DNA content: 21.5 ± 3.39 ng/follicle, n = 40; P < 0.002 vs. control) (Fig. 2A). The increases in cell number equivalence, follicular volume, and daily growth rate were maximal on Day 3 of culture (Fig. 2, A and B). Histological examination of the HPS-stained follicles previously cultured over 6 days in the presence of gonadotropin indicated a well-preserved follicular structure (Fig. 4) containing granulosa cells, theca cells, and intact basement membrane (for Day 2, see Fig. 4B; for Day 6, see Fig. 4C). Theca cells on Day 6 of culture (Fig. 4C) appeared more cuboidal compared to those of follicles of similar stage in situ (Fig. 4D), and freshly isolated follicles (for Day 0, see Fig. 4A). When in vitro FSH exposure (100 ng/ml) was delayed for 2 days (i.e., FSH present on Days 3–6), the follicles were also responsive to the gonadotropin, although overall follicular growth and the daily growth rate were markedly decreased (P < 0.002) (Fig. 2).



View larger version (129K):
[in this window]
[in a new window]
 
FIG. 4. Comparison of follicular morphology at Day 0 (A), Day 2 (B), and Day 6 (C) of culture in the presence of FSH and of ovary in vivo (D). The HPS-stained follicular section shows thecal cells (TC), granulosa cells (GC), oocyte (OC), and basement membrane ({Delta})

FSH Increases XIAP Expression in Cultured Ovarian Follicles

To determine if XIAP expression is regulated by the gonadotropin during follicular development and atresia in vitro, changes in XIAP content and apoptosis in sections of cultured follicles were examined by IHC and TUNEL, respectively (Fig. 5A). Whereas follicles cultured in the absence of FSH for 2 and 4 days showed low XIAP immunoreactivity and detectable apoptotic signal, addition of FSH (100 ng/ml) to the culture medium markedly increased XIAP expression (Fig. 5A) and decreased the apoptotic signal (Fig. 5A). In addition, gonadotropin also significantly increased follicular XIAP content (P < 0.05) (Fig. 6) and suppressed apoptotic DNA fragmentation (P < 0.05) (Fig. 6).



View larger version (46K):
[in this window]
[in a new window]
 
FIG. 5. Effects of FSH (A) and XIAP gene manipulation (B) on rat follicle cultures showing XIAP content and apoptosis. A) Follicles were cultured in the absence or presence of FSH (100 ng/ml) for 2 or 4 days. B) Follicles were injected with adenoviral LacZ (control, MOI = 20) or full-length XIAP sense (MOI = 3) or antisense (MOI = 20) cDNA, and FSH (5 ng/ml) was added to the cultures 24 h thereafter. The follicles were cultured with gonadotropin for another 3 days, fixed, and paraffin-sectioned. The TUNEL assay (green) and IHC of XIAP (red) were performed as described in Materials and Methods. Different sizes of the labels "XIAP" and "TUNEL" signify relative intensities of signals. An image from 16 representative follicles is shown for each treatment group



View larger version (34K):
[in this window]
[in a new window]
 
FIG. 6. Effects of FSH on rat follicular XIAP content and apoptotic DNA fragmentation. Follicles were cultured in the absence (CTL) or presence of FSH (100 ng/ml) for 4 days. The XIAP and tubulin contents were determined by Western blot analysis, and apoptosis was determined by 3' end-labeling of DNA fragments. Representative images (A) and quantitative analysis (B) of follicular XIAP contents (normalized against respective tubulin levels and expressed as fold of control) and DNA fragmentation (expressed by the ratio of <4K [4000 bp] fragmented DNA and respective genomic DNA), are shown. Because XIAP content and the apoptotic DNA fragmentation were expressed as fold of control, they were arcsine square root-transformed before one-way ANOVA. Twenty-five (Western blot) and 10 (apoptosis assessment) follicles from the same treatment group were pooled and served as one sample. Values represent the mean ± SEM of three independent experiments. *P < 0.05 vs. CTL.

Effects of XIAP Down-Regulation and Overexpression in Cultured Follicles

Follicles injected with adenoviral XIAP antisense cDNA (MOI = 20) and cultured in the presence of FSH (5 ng/ml) exhibited lower XIAP immunointensity compared to gonadotropin-treated follicles injected with adenoviral LacZ (Fig. 5B). The XIAP down-regulated follicles also had a stronger TUNEL-positive signal compared to the LacZ control (Fig. 5B). The XIAP antisense also markedly decreased XIAP contents (P < 0.05) (Fig. 7) and significantly increased DNA fragmentation (P < 0.05) (Fig. 7). In addition, infection of the follicles with XIAP antisense cDNA significantly attenuated the FSH-induced follicular growth as indicated by a marked decrease in DNA content (P < 0.05) and follicular volume (P < 0.05) but was ineffective in the absence of gonadotropin (Fig. 8). Two-way ANOVA shows a significant FSH effect (P < 0.001), antisense effect (P < 0.001), and interaction between these factors (P < 0.001), brought about by the observation that the XIAP antisense was more effective in follicles cultured in the presence than in the absence of gonadotropin.



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 7. Effects of XIAP gene manipulation on rat follicular XIAP content and apoptotic DNA fragmentation. Follicles were injected with adenoviral LacZ (LacZ; MOI = 20) or full-length XIAP sense (XIAP-S; MOI = 3) or antisense (XIAP-AS; MOI = 20) cDNA, and FSH (5 ng/ml) was added to the cultures 24 h thereafter. The follicles were cultured with gonadotropin for another 3 days. The XIAP and tubulin contents were determined by Western blot analysis, and apoptosis was determined by 3' end-labeling of DNA fragments. Representative images (A) and quantitative analysis (B) of follicular XIAP contents (normalized against respective tubulin levels and expressed as fold of control) and DNA fragmentation (expressed by the ratio of <4K [4000 bp] fragmented DNA and respective genomic DNA) are shown. Because the XIAP content and the apoptotic DNA fragmentation were expressed as fold of control, they were arcsine square root-transformed before one-way ANOVA. Twenty-five (Western blot) and 10 (apoptosis assessment) follicles from the same treatment group were pooled and served as one sample. Values represent the mean ± SEM of three independent experiments. +P < 0.05, ++P < 0.01 vs. LacZ



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 8. Effects of XIAP gene manipulation on follicular DNA content (top panels) and volume (lower panels) with or without FSH. After 1 day of culture in the absence of FSH, follicles were injected with adenoviral LacZ (control, MOI = 20) or full-length XIAP sense (MOI = 3) or antisense (MOI = 20) cDNA, and FSH (5 ng/ml) was added to the cultures 24 h thereafter. The follicles were cultured in the absence or presence of gonadotropin (5 ng/ml) for another 3 days. Follicular volume change was defined as the growth between Day 0 and 4 of culture. Following confirmation that no interreplicate differences existed in each experiment (one-way ANOVA), individual observations from all replicates were pooled for analysis by two-way (repeated-measure) ANOVA. Values represent the mean ± SEM of a total of 36 follicles from three independent experiments. *P < 0.05 (vs. CTL-LacZ), **P < 0.01 (vs. CTL-LacZ), +P < 0.05 (vs. FSH-LacZ)

On the other hand, follicles injected with XIAP sense and subsequently cultured in the low concentration of FSH (5 ng/ml) showed high XIAP immunointensity and less-intense TUNEL signal compared to adenoviral LacZ-injected follicles (Fig. 5B). Although a range in the intensity in both XIAP and TUNEL signals was observed within each experimental group, the differences between groups (LacZ vs. XIAP sense vs. XIAP antisense) were obvious. Similarly, XIAP sense infection significantly increased XIAP protein content (P < 0.01) (Fig. 7) and suppressed apoptotic DNA fragmentation (P < 0.05) (Fig. 7). The increase in XIAP expression following adenoviral XIAP sense infection was not associated with any significant changes in DNA content and follicular volume (P > 0.05) (Fig. 8) in the absence of FSH. In contrast, follicles infected with XIAP sense and cultured in the presence of low concentration of FSH (5 ng/ml) showed a marked increase in DNA content (13.28 ± 1.89 ng/follicle vs. 6.85 ± 0.82 ng/follicle, n = 36, P < 0.05) and follicular volume (22.88 ± 3.29 nl vs. 10.85 ± 2.02 nl, n = 36, P < 0.05) compared to the FSH-stimulated and LacZ-infected follicles. Analysis of variance demonstrates a significant FSH effect (P < 0.001) and XIAP sense effect (P < 0.001), and an interaction between the factors (P < 0.001) (Fig. 8), because of a greater influence by XIAP overexpression on follicular growth in the presence of gonadotropin.

Influence of FSH on Granulosa Cell XIAP Expression and Apoptosis In Vitro

To test if the FSH-induced follicular growth and increase in cell number in vitro is caused by a direct action of gonadotropin on granulosa cells to stimulate proliferation and/or suppress apoptosis, granulosa cells were cultured for 48 h in the absence or presence of FSH (100 ng/ml). Analysis of variance indicates that although FSH significantly decreased granulosa cell apoptosis compared to control (P < 0.01), total granulosa cell number was markedly lower in the presence of gonadotropin (P < 0.02, two-way ANOVA) (Table 1), irrespective of up- or down-regulation of XIAP (P < 0.05, Tukey test).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Effects of FSH, LacZ, and XIAP cDNA expression on cell number and apoptosis in primary granulosa cell culture.a

To determine if FSH has a direct regulatory role in granulosa cell XIAP expression, the influence of gonadotropin (0–150 ng/ml) on XIAP contents in cultured granulosa cells was assessed during 24- and 48-h culture periods. The FSH significantly increased granulosa cell XIAP content in a concentration-dependent manner (Fig. 9). Arcsine square root-transformed two-way ANOVA indicates a significant effect of concentration (P < 0.01) but not of time (P > 0.05). To assess if XIAP may play an important role in the regulation of granulosa cell fate, the XIAP level was manipulated by adenoviral expression of XIAP sense and antisense (MOI = 5 and 20, respectively) in the absence and presence of FSH (100 ng/ml). Overexpression of XIAP alone (i.e., in the absence of FSH) markedly suppressed granulosa cell apoptosis (P < 0.05) (Table 1). In addition, adenoviral XIAP sense cDNA delivery potentiated the antiapoptotic action of FSH compared with LacZ infection (P < 0.05) (Table 1). In the absence of FSH, XIAP antisense expression increased follicular apoptosis compared to LacZ control (P < 0.05) (Table 1). Moreover, in the presence of gonadotropin, adenoviral XIAP antisense infection markedly attenuated the cell survival effect of FSH and increased the number of apoptotic granulosa cells (P < 0.05).



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 9. Effects of FSH on granulosa cell XIAP content in vitro. Granulosa cells were cultured for 24 and 48 h in the serum-free RPMI 1640 in the presence of different concentrations of FSH (0–150 ng/ml). The XIAP and tubulin contents were determined by Western blot analysis. Representative images and densitometric data of XIAP contents, normalized against respective tubulin levels and expressed as fold of control, are shown. Because the XIAP content was expressed as fold of control, it was arcsine square root-transformed before two-way ANOVA. Values represent the mean ± SEM of three independent experiments. *P < 0.05 vs. control (no FSH)


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The FSH is an important survival factor for preantral and antral follicular development in vivo [1, 28]. Whereas administration of gonadotropin induces ovarian follicular development in immature animals, gonadotropin withdrawal by anti-eCG antibody treatment resulted not only in cessation of follicular growth but also in atresia [3]. In the present study, we have successfully established a rat follicle culture system and have demonstrated that FSH stimulates rat ovarian follicular growth and induces antral formation in a 6-day culture period. Our findings are consistent with the results of recent studies involving cultures of bovine, baboon, mouse, rat, and hamster ovarian follicles [2933]. This culture system may prove to be useful for assessment of the endocrine control of follicular development and atresia.

The fate of a developing follicle (continual growth and development vs. atresia) is determined by the fate of its cells (proliferation and differentiation vs. apoptosis), which in turn is regulated by their relative expression of "death" and "survival" genes. Thus, follicular development may be a consequence of suppression of cell death genes or overexpression of cell survival genes. Follicular atresia is associated with decreased granulosa cell IAP contents, and gonadotropin administration results in the up-regulation of follicular IAPs [18]. Although it is well established that granulosa cell survival and apoptosis are the cellular basis of follicular development and atresia, respectively, whether the changes in the expression of these intracellular antiapoptotic proteins are coincidental or causally related to these gonadotropin-regulated processes is not known.

Transgenic and knockout animals have been used extensively to assess the role of the gene (or genes) of interest in physiological processes. However, these approaches are often plagued with systemic complications because of overall ill health of the animals, which often affects normal development. The IAPs are ubiquitous and found in high abundance in proliferating mammalian cells [34]. Despite a newly established NAIP knockout mice model [35], no XIAP knockout animal model was available until recently [36] to enable assessment of the role of XIAP in the gonadotrophic regulation of follicular development and atresia. Whereas no apparent differences were observed between the ability of cells from the XIAP-deficient and wild-type mice to undergo caspase-dependent or -independent apoptosis, the cellular levels of other IAPs (e.g., cIAP-1 and cIAP-2) were unexpectedly higher, suggesting the existence of a possible compensatory mechanism that leads to the up-regulation of other IAP family members when XIAP expression is lost. However, when and how this compensatory mechanism is triggered is still unclear. By coupling an adenoviral gene-delivery system to the above-mentioned follicle culture model, we have demonstrated in the present study that XIAP is important in the gonadotrophic regulation of these ovarian developmental processes. In the present study, FSH increased XIAP expression, suppressed apoptosis, and stimulated follicular growth (as evidenced by increases in DNA content, cell number, and follicular volume). In contrast, antisense XIAP decreased FSH-induced XIAP, induced apoptosis, and prevented follicular development. These findings suggest that XIAP plays an important role in FSH-stimulated follicular development and serves as an antiapoptotic factor in rat ovarian follicles. Moreover, adenoviral XIAP sense infection in the cultured follicles increased XIAP contents and attenuated follicular apoptosis in both the absence and the presence of gonadotropin. Follicles infected with XIAP sense and cultured in the presence of low FSH concentration (5 ng/ml) showed a marked increase in follicular development (as evidenced by increases in DNA content and follicular volume) compared to the FSH-stimulated but LacZ-infected follicles. The XIAP sense was ineffective in the absence of gonadotropin. These findings suggest that whereas XIAP is necessary for the suppression of apoptosis, it alone is insufficient to promote follicular growth. These findings do not exclude the possible involvement of other IAPs in the gonadotrophic regulation of follicular development and atresia. In this context, eCG administration up-regulates granulosa cell HIAP-2 expression in immature rats, suppresses granulosa cell apoptosis, and induces follicular growth, whereas gonadotropin withdrawal suppresses HIAP-2 expression and induces apoptosis and follicular atresia [18]. Moreover, suppression of ovarian NAIP expression with antisense oligonucleotides evoked a decrease in the number of morphologically normal ovulated oocytes, implying an indirect involvement of NAIP in germ cell development via enhancement of granulosa cell survival [19].

The mode of action of XIAP in granulosa cell survival during ovarian follicular development has not been investigated, although we have recently shown that XIAP inhibits caspase-3 in ovarian epithelial cancer cells [3739]. It is well established that IAPs modulate cell death pathways by inhibiting caspases [1517, 3743] and that the BIR domains are essential for their inhibitory action [40]. Specifically, XIAP possesses two different caspase-inhibitory activities, which can be attributed to distinct domains within XIAP. The BIR3 of XIAP is a specific inhibitor of caspase-9, whereas BIR2 plus the linker region of BIR1 and BIR2 is specific for caspase-3 and caspase-7 [4042]. The IAPs suppress Fas ligand- and TNF{alpha}-induced apoptosis by directly inhibiting caspase-3 and caspase-7 activation and activity [1517], but they are ineffective in the activation of caspase-1, caspase-6, or caspase-10 [15]. In addition, XIAP modulates the cytochrome c/caspase-9-dependent mitochondrial death pathway. The mammalian HIAP-1, HIAP-2, and XIAP interfere with the function of caspase-9 by binding to inactive procaspase-9, thereby preventing its processing and activation [40, 43]. However, whether XIAP functions in this manner in the ovary remains to be determined. Interestingly, recent studies have shown that overexpression of XIAP increases phospho-Akt content in cultured rat granulosa cells [39] and human ovarian cancer cells [44]. This raises the possibility that XIAP may exert its antiapoptotic action via up-regulation of the PI3K/Akt pathway through a caspase-independent mechanism.

Our present findings indicate that although FSH is capable of increasing follicular cell number (as indicated by increased Alamar Blue reduction and DNA content) and growth in a follicle culture system, it fails to stimulate proliferation when added to granulosa cell primary cultures. The reason for this apparent discrepancy is not clear, but the granulosa cells used in the present studies may have been exposed to LH (in the eCG preparation) in vivo before isolation and culture, resulting in premature luteinization of the cells and, consequently, exit from the cell cycle. Alternatively, in addition to being a cell survival factor for granulosa cells via its direct action on XIAP expression, FSH may also stimulate follicular secretion of one or more mitogens, which in turn increases granulosa cell proliferation and ovarian follicular growth. In this context, FSH-induced follicular DNA synthesis in the hamster is mediated by follicular secretion and action of epidermal growth factor [45]. In addition to gonadotropins, various ovarian factors are believed to play an important role in rescuing follicles from apoptotic demise during follicular development [46]. Previous studies from our laboratory have shown that FSH increases follicular transforming growth factor {alpha} secretion and that this theca-derived growth factor induces follicular growth in vitro [47]. In this context, recent studies using a coculture of bovine ovarian granulosa and theca cells have shown that the theca cells are essential in protecting granulosa cells from undergoing apoptosis, a process that is follicular stage-specific. These results suggest that theca cells may secrete one or more survival factors necessary for maintenance of granulosa cell viability, although the identity of this factor is yet to be defined [48]. It is also possible that the regulation of follicular growth by FSH is mediated by the action of TNF{alpha}. Previous studies have shown that gonadotropins increase ovarian TNF{alpha} content during follicular development [49] and that this cytokine is antiapoptotic and capable of inducing XIAP expression in rat granulosa cells [50]. The intraovarian regulation of follicular development and atresia by gonadotropin remains to be fully explored.

In conclusion, a follicle culture system coupled to an adenoviral gene-delivery procedure has been established, to our knowledge for the first time. Using this approach, we have demonstrated that XIAP plays an important role in the determination of granulosa cell fate following FSH challenge and that changes in XIAP expression induced by gonadotropin are critical for the maintenance of normal follicular growth and development.


    ACKNOWLEDGMENTS
 
We would like to express our appreciation to Dr. Wai-sum O (Department of Anatomy, University of Hong Kong, Hong Kong) for her invaluable advice on the follicle culture conditions, on the follicle embedding procedure for histological processing, and on the preparation of the manuscript. We also thank Dr. Eric LaCasse (Ægera Therapeutics, Inc., Ottawa, ON, Canada) for providing the XIAP antibody as well as the adenoviral LacZ, XIAP sense, and XIAP antisense cDNAs. The technical support of Ms. Dawn King, Ms. Nga Young, and Mr. William Parks (Histology Laboratory, Department of Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada) is very much appreciated. We would like to thank Dr. Yubo Ren (Ottawa Health Research Institute, Ottawa, ON, Canada) for his technical help in confocal microscopy, Dr. George Wells (Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada) for his advice on statistical analyses, and Dr. Charbel Taraff (Biology Department, American University of Beirut, Beirut, Lebanon) aided in the establishment of the rat follicle cultures.


    FOOTNOTES
 
1 Supported by a grant from the Canadian Institutes of Health Research (MOP-10369 to B.K.T.). Y.W. is a recipient of an NSERC scholarship. Back

2 Correspondence: Benjamin K. Tsang, Ottawa Health Research Institute, The Ottawa Hospital (Civic Campus), 725 Parkdale Avenue, Ottawa, ON, Canada K1Y 4E9. FAX: 613 761 4403; btsang{at}ohri.ca Back

Received: 12 June 2002.

First decision: 29 June 2002.

Accepted: 3 September 2002.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Carroll J, Whittingham DG, Wood MJ. Effect of gonadotropin environment on growth and development of isolated mouse primary ovarian follicles. J Reprod Fertil 1991 93:71-79[Abstract/Free Full Text]
  2. Tilly JL, Tilly KI. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology 1995 136:242-252[Abstract]
  3. Boone DL, Carnegie JA, Rippstein PU, Tsang BK. Induction of apoptosis in equine chorionic gonadotropin (eCG)-primed rat ovaries by anti-eCG antibody. Biol Reprod 1997 57:420-427[Abstract]
  4. Picton HM, McNeilly AS. Evidence to support a follicle-stimulating hormone threshold theory for follicle selection in ewes chronically treated with gonadotropin-releasing hormone agonist. J Reprod Fertil 1991 93:43-51[Abstract/Free Full Text]
  5. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996 379:349-353[CrossRef][Medline]
  6. Partheniou F, Kelsey SM, Srinivasula SM, Newland AC, Alnemri ES, Jia L. c-Iap1 blocks TNF{alpha}-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells. Biochem Biophys Res Commun 2001 287:181-189[CrossRef][Medline]
  7. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, Kang X. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995 80:167-178[CrossRef][Medline]
  8. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997 3:917-921[CrossRef][Medline]
  9. Kasof GM, Gomes BC. Livin, a novel inhibitor-of-apoptosis (IAP) family member. J Biol Chem 2001 276:3238-3246[Abstract/Free Full Text]
  10. Lin JH, Deng G, Huang Q, Morser J. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2000 279:820-831[CrossRef][Medline]
  11. Farahani R, Fong WG, Korneluk RG, Mackenzie AE. Genomic organization and primary characterization of miap-3: the murine homologue of human X-linked IAP. Genomics 1997 42:514-518[CrossRef][Medline]
  12. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000 288:874-877[Abstract/Free Full Text]
  13. Gruslin A, Qiu Q, Tsang BK. Influence of maternal smoking on trophoblast apoptosis throughout development: possible involvement of XIAP regulation. Biol Reprod 2001 65:1164-1169[Abstract/Free Full Text]
  14. Roth W, Wagenknecht B, Klumpp A. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ 2001 8:403-410[CrossRef][Medline]
  15. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997 388:300-304[CrossRef][Medline]
  16. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997 16:6914-6925[CrossRef][Medline]
  17. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999 15:269-290[CrossRef][Medline]
  18. Li J, Kim JM, Liston P, Li M, Miyazaki T, Mackenzie AE, Korneluk RG, Tsang BK. Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia. Endocrinology 1998 139:1321-1328[Abstract/Free Full Text]
  19. Matsumoto K, Nakayama T, Sakai H, Tanemura K, Osuga H, Sato E, Ikeda JE. Neuronal apoptosis inhibitory protein (NAIP) may enhance the survival of granulosa cells thus indirectly affecting oocyte survival. Mol Reprod Dev 1999 54:103-111[CrossRef][Medline]
  20. Johnson AL, Bridgham JT, Digby MR, Lowenthal JW. Expression of the inhibitor of T-cell apoptosis (ita) gene in hen ovarian follicles during development. Biol Reprod 1998 58:414-420[Abstract/Free Full Text]
  21. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 1996 93:1320-1324[Abstract/Free Full Text]
  22. Rose UM, Hanssen RG, Kloosterboer HJ. Development and characterization of an in vitro ovulation model using mouse ovarian follicles. Biol Reprod 1999 61:503-511[Abstract/Free Full Text]
  23. Karakji EG, Tsang BK. Follicular stage-dependent regulation of rat granulosa cell plasminogen activator system by transforming growth factor-{alpha} in vitro. Biol Reprod 1995 52:411-418[Abstract]
  24. Bull S, Langezaal I, Clothier R, Coecke SA. Genetically engineered cell-based system for detecting metabolism-mediated toxicity. Alternatives Lab Anim 2001 29:703-716
  25. Ahmed SA, Gogal RM Jr, Walsh JE. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994 170:211-224[CrossRef][Medline]
  26. Kim JM, Yoon YD, Tsang BK. Involvement of the Fas/Fas ligand system in p53-mediated granulosa cell apoptosis during follicular development and atresia. Endocrinology 1999 140:2307-2317[Abstract/Free Full Text]
  27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992 119:493-501[Abstract/Free Full Text]
  28. Chun SY, Eisenhauer KM, Minami S, Billig H, Perlas E, Hsueh AJ. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology 1996 137:1447-1456[Abstract]
  29. Fortune JE, Kito S, Wandji SA, Srsen V. Activation of bovine and baboon primordial follicles in vitro. Theriogenology 1998 49:441-449[CrossRef][Medline]
  30. Liu X, Andoh K, Mizunuma H, Kamijo T, Kikuchi N, Yamada K, Ibuki Y. Effects of recombinant human FSH (rhFSH), urinary purified FSH (uFSH), and hMG on small preantral follicles and tertiary follicles from normal adult and androgen-sterilized female mice. Fertil Steril 2000 73:372-380[CrossRef][Medline]
  31. Roy SK. Regulation of transforming growth factor-ß-receptor type I and type II messenger ribonucleic acid expression in the hamster ovary by gonadotropins and steroid hormones. Biol Reprod 2000 62:1858-1865[Abstract/Free Full Text]
  32. Gutierrez CG, Ralph JH, Telfer EE, Wilmut I, Webb R. Growth and antrum formation of bovine preantral follicles in long-term culture in vitro. Biol Reprod 2000 62:1322-1328[Abstract/Free Full Text]
  33. McGee EA, Perlas E, LaPolt PS, Tsafriri A, Hsueh AJ. Follicle-stimulating hormone enhances the development of preantral follicles in juvenile rats. Biol Reprod 1997 57:990-998[Abstract]
  34. Hay BA, Wassarman DA, Rubin GM. Drosophila homologues of baculovirus inhibitor of apoptosis proteins function to block cell death. Cell 1995 83:1253-1262[CrossRef][Medline]
  35. Holcik M, Thompson CS, Yaraghi Z, Lefebvre CA, Mackenzie AE, Korneluk RG. The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury. Proc Natl Acad Sci U S A 2000 97:2286-2290[Abstract/Free Full Text]
  36. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. Characterization of XIAP-deficient mice. Mol Cell Biol 2001 21:3604-3608[Abstract/Free Full Text]
  37. Sasaki H, Kotsuji F, Tsang BK. Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein. Gynecol Oncol 2002 85:339-350[CrossRef][Medline]
  38. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 2000 60:5659-5666[Abstract/Free Full Text]
  39. Asselin E, Mills GB, Tsang BK. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 2001 61:1862-1868[Abstract/Free Full Text]
  40. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998 273:7787-7790[Abstract/Free Full Text]
  41. Suzuki Y, Nakabayashi Y, Nakata K, Reed JC, Takahashi R. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J Biol Chem 2001 276:27058-27063[Abstract/Free Full Text]
  42. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999 18:5242-5251[CrossRef][Medline]
  43. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998 17:2215-2223[CrossRef][Medline]
  44. Asselin E, Wang Y, Tsang BK. X-linked inhibitor of apoptosis protein activates phosphatidylinostitol 3-kinase/Akt pathways in rat granulosa cells during follicular development. Endocrinology 2001 142:2451-2457[Abstract/Free Full Text]
  45. Roy SK, Greenwald GS. Mediation of follicle-stimulating hormone action on follicular deoxyribonucleic acid synthesis by epidermal growth factor. Endocrinology 1991 129:1903-1908[Abstract/Free Full Text]
  46. Kaipia A, Hsueh AJ. Regulation of ovarian follicle atresia. Annu Rev Physiol 1997 59:349-363[CrossRef][Medline]
  47. Wang Y, Asselin E, Tsang BK. Involvement of transforming growth factor {alpha} in the regulation of rat ovarian X-linked inhibitor of apoptosis protein expression and follicular growth by follicle-stimulating hormone. Biol Reprod 2002 66:1672-1680[Abstract/Free Full Text]
  48. Tajima K, Orisaka M, Hosokawa K, Amsterdam A, Kotsuji F. Effects of ovarian theca cells on apoptosis and proliferation of granulosa cells: changes during bovine follicular maturation. Biol Reprod 2002 66:1635-1639[Abstract/Free Full Text]
  49. Darbon JM, Oury F, Laredo J, Bayard F. Tumor necrosis factor-{alpha} inhibits follicle-stimulating hormone-induced differentiation in cultured rat granulosa cells. Biochem Biophys Res Commun 1989 163:1038-1046[CrossRef][Medline]
  50. Xiao CW, Ash C, Tsang BK. X-linked inhibitor of apoptosis protein prevents tumor necrosis factor-induced apoptosis in rat granulosa cells. Endocrinology 2001 142:557-563[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung
Gonadotropins and Ovarian Cancer
Endocr. Rev., June 1, 2007; 28(4): 440 - 461.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. Wang and B. K Tsang
Nodal signalling and apoptosis
Reproduction, May 1, 2007; 133(5): 847 - 853.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. S. Sleer and C. C. Taylor
Cell-Type Localization of Platelet-Derived Growth Factors and Receptors in the Postnatal Rat Ovary and Follicle
Biol Reprod, March 1, 2007; 76(3): 379 - 390.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Wang, J.-Y. Jiang, C. Zhu, C. Peng, and B. K. Tsang
Role and Regulation of Nodal/Activin Receptor-Like Kinase 7 Signaling Pathway in the Control of Ovarian Follicular Atresia
Mol. Endocrinol., October 1, 2006; 20(10): 2469 - 2482.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Orisaka, S. Orisaka, J.-Y. Jiang, J. Craig, Y. Wang, F. Kotsuji, and B. K. Tsang
Growth Differentiation Factor 9 Is Antiapoptotic during Follicular Development from Preantral to Early Antral Stage
Mol. Endocrinol., October 1, 2006; 20(10): 2456 - 2468.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. K. Kreeger, N. N. Fernandes, T. K. Woodruff, and L. D. Shea
Regulation of Mouse Follicle Development by Follicle-Stimulating Hormone in a Three-Dimensional In Vitro Culture System Is Dependent on Follicle Stage and Dose
Biol Reprod, November 1, 2005; 73(5): 942 - 950.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
I Demeestere, J Centner, C Gervy, Y Englert, and A Delbaere
Impact of various endocrine and paracrine factors on in vitro culture of preantral follicles in rodents
Reproduction, August 1, 2005; 130(2): 147 - 156.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.-Y. Jiang and B. K. Tsang
Optimal Conditions for Successful In Vitro Fertilization and Subsequent Embryonic Development in Sprague-Dawley Rats
Biol Reprod, December 1, 2004; 71(6): 1974 - 1979.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
P. A Fowler and N. Spears
The cultured rodent follicle as a model for investigations of gonadotrophin surge-attenuating factor (GnSAF) production
Reproduction, June 1, 2004; 127(6): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Uma, P. Muraly, S. Verma-Kumar, and R. Medhamurthy
Determination of Onset of Apoptosis in Granulosa Cells of the Preovulatory Follicles in the Bonnet Monkey (Macaca radiata): Correlation with Mitogen-Activated Protein Kinase Activities
Biol Reprod, October 1, 2003; 69(4): 1379 - 1387.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
68/2/610    most recent
biolreprod.102.007807v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Tsang, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Tsang, B. K.
Agricola
Right arrow Articles by Wang, Y.
Right arrow Articles by Tsang, B. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS